Adaptation of a protocol for the automated solid-phase phosphoramidite synthesis of oligodeoxyribonucleotides for the preparation of their N-unsubstituted phosphoramidate analogues (P-NH2)

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A new approach to the automated synthesis of N-unsubstituted phosphoramidate oligodeoxyribonucleotides (P-NH2) based on an optimized solid-phase phosphoramidite protocol using the Staudinger reaction has been proposed. The rapid and efficient oxidation of model P(III)-containing phosphite triethers by the organic azide (9H-fluoren-9-yl)methylcarbonylazide (FmocN3) to the corresponding phosphamides –(OPO(OR)(NFmoc))–, where R is a residue of nucleoside or alkyl nature, has been demonstrated. Removal of the alkaline-labile fluorenyl group from the modified internucleoside linkage allows the production of electroneutral, under physiological conditions of pH ~7, N-unsubstituted phosphoramidate (–(OPO(O)(NH2))– or (P-NH2)) residues in the oligonucleotide chain instead of the classical negatively charged phosphodiester (–(OPO(O)(O)(O¯))–) or (P-O)) residues. In optimizing the synthetic protocol, it has been demonstrated that to improve the efficiency of P-NH2-oligonucleotide synthesis, it is necessary to include an additional Fmoc-group cleavage step in the automatic synthesis protocol after each oxidation step of the growing oligomer chain via the Staudinger reaction. An almost complete absence of dependence of the P-NH2-oligonucleotide yield on both the localization of the P-NH2-strand in the chain and the type of dinucleotide fragment being modified was shown. A set of mono- and bis-modified octadeoxyribonucleotides was obtained, and a detailed study of the thermal stability of complementary DNA/DNA complexes under different buffer conditions was performed. It was shown that under high ionic strength conditions (1 M NaCl, pH 7.2), the introduction of a single P-NH2 strand reduced the thermostability of the DNA complex by an average of 1.3°C. When the ionic strength of the solution decreases, the destabilizing effect of the P-NH2-modification decreases significantly, which further confirms the electroneutral status of the introduced phosphoramidate linkage. Thus, we have developed a protocol for the preparation of partially modified oligonucleotide derivatives bearing uncharged but isostructured to native P-O-strands – phosphoramidate residues P-NH2.

全文:

受限制的访问

作者简介

E. Malova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences

编辑信件的主要联系方式.
Email: malova.ev.an@gmail.com
俄罗斯联邦, prosp. Acad. Lavrentyeva 8, Novosibirsk, 630090

I. Pyshnaya

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences

Email: pyshnaya@niboch.nsc.ru
俄罗斯联邦, prosp. Acad. Lavrentyeva 8, Novosibirsk, 630090

M. Meschaninova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences

Email: pyshnaya@niboch.nsc.ru
俄罗斯联邦, prosp. Acad. Lavrentyeva 8, Novosibirsk, 630090

D. Pyshnyi

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences

Email: pyshnaya@niboch.nsc.ru
俄罗斯联邦, prosp. Acad. Lavrentyeva 8, Novosibirsk, 630090

参考

  1. Knouse K., Flood D., Vantourout J., Schmidt M., McDonald I., Eastgate M., Baran P. // ACS Cent. Sci. 2021. V. 7. P. 1473–1485. https://doi.org/10.1021/acscentsci.1c00487
  2. Benner S., Hurter D. // Bioorg. Chem. 2002. V. 30. P. 62–80. https://doi.org/10.1006/bioo.2001.1232
  3. Agrawal S. // Trends Biotechnol. 1996. V. 14. P. 376–387. https://doi.org/10.1016/0167-7799(96)10053-6
  4. Duffy K., Arangundy-Franklin S., Holliger P. // BMC Biol. 2020. V. 18. P. 112. https://doi.org/10.1186/s12915-020-00803-6
  5. Oberemok V., Laikova K., Repetskaya A., Kenyo I., Gorlov M., Kasich I., Krasnodubets A., Gal’chinsky N., Fomochkina I., Zaitsev A., Bekirova V., Seidosmanova E., Dydik K., Meshcheryakova A., Nazarov S., Smagliy N., Chelengerova E., Kulanova A., Deri K., Subbotkin M., Useinov R., Shumskykh M., Kubyshkin A. // Molecules. 2018. V. 23. P. 1302. https://doi.org/10.3390/molecules23061302
  6. Clavé G., Reverte M., Vasseur J.-J., Smietana M. // RSC Chem. Biol. 2021. V. 2. P. 94–150. https://doi.org/10.1039/D0CB00136H
  7. Kandasamy P., Liu Y., Aduda V., Akare S., Alam R., Andreucci A., Boulay D., Bowman K., Byrne M., Cannon M., Chivatakarn O., Shelke J.D., Iwamoto N., Kawamoto T., Kumarasamy J., Lamore S., Lemaitre M., Lin X., Longo K., Looby R., Marappan S., Metterville J., Mohapatra S., Newman B., Paik I.H., Patil S., Purcell-Estabrook E., Shimizu M., Shum P., Standley S., Taborn K., Tripathi S., Yang H., Yin Y., Zhao X., Dale E., Vargeese C. // Nucleic Acids Res. 2022. V. 50. P. 5401–5423. https://doi.org/10.1093/nar/gkac037
  8. Egli M., Manoharan M. // Nucleic Acids Res. 2023. V. 51. P. 2529–2573. https://doi.org/10.1093/nar/gkad067
  9. de la Torre B., Albericio F. // Molecules. 2023. V. 28. P. 1038. https://doi.org/10.3390/molecules28031038
  10. Nielsen P. // Mol. Biotechnol. 2004. V. 26. P. 233–248. https://doi.org/10.1385/MB:26:3:233
  11. Nielsen P. // Chem. Biodivers. 2010. V. 7. P. 786–804. https://doi.org/10.1002/cbdv.201000005
  12. Arangundy-Franklin S., Taylor A., Porebski B., Genna V., Peak-Chew S., Vaisman A., Woodgate R., Orozco M., Holliger P. // Nat. Chem. 2019. V. 11. 533– 542. https://doi.org/10.1038/s41557-019-0255-4
  13. Peyrottes S. // Nucleic Acids Res. 1996. V. 24. P. 1841– 1848. https://doi.org/10.1093/nar/24.10.1841
  14. Chubarov A.S., Oscorbin I.P., Novikova L.M., Filipenko M.L., Lomzov A.A., Pyshnyi D.V. // Diagnostics. 2023. V. 13. P. 250. https://doi.org/10.3390/diagnostics13020250
  15. Dong Z., Chen X., Zhuo R., Li Y., Zhou Z., Sun Y., Liu Y., Liu M. // BMC Biol. 2023. V. 21. P. 95. https://doi.org/10.1186/s12915-023-01599-x
  16. Sarkar S. // Biopolymers. 2023. V. 115. P. e23567. https://doi.org/10.1002/bip.23567
  17. Lomzov A.A., Kupryushkin M.S., Dyudeeva E.S., Pyshnyi D.V. // Russ. J. Bioorg. Chem. 2021. V. 47. P. 461–468. https://doi.org/10.1134/S1068162021020151
  18. Summerton J. // Int. J. Pept. Res. Ther. 2003. V. 10. P. 215–236. https://doi.org/10.1007/s10989-004-4913-y
  19. Bhadra J., Pattanayak S., Sinha S. // Curr. Protoc. Nucleic Acid Chem. 2015. V. 62. P. 4.65.1–4.65.26. https://doi.org/10.1002/0471142700.nc0465s62
  20. Braasch D., Nulf C., Corey D. // Curr. Protoc. Nucleic Acid Chem. 2002. V. 9. P. 4.11.1–4.11.18. https://doi.org/10.1002/0471142700.nc0411s09
  21. Kostov O., Páv O., Rosenberg I. // Curr. Protoc. Nucleic Acid Chem. 2017. V. 70. P. 4.76.1–4.76.22. https://doi.org/10.1002/cpnc.35
  22. Micklefield J. // Curr. Med. Chem. 2001. V. 8. P. 1157– 1179. https://doi.org/10.2174/0929867013372391
  23. Lee H., Jeon J., Lim J., Choi H., Yoon Y., Kim S. // Org. Lett. 2007. V. 9. P. 3291–3293. https://doi.org/10.1021/ol071215h
  24. Купрюшкин М.С., Пышный Д.В., Стеценко Д.А. // Act. Nat. 2014. Т. 6. C. 116–118. https://doi.org/10.32607/20758251-2014-6-4-116-118
  25. Kuznetsov N.A., Kupryushkin M.S., Abramova T.V., Kuznetsova A.A., Miroshnikova A.D., Stetsenko D.A., Pyshnyi D.V., Fedorova O.S. // Mol. Biosyst. 2016. V. 12. P. 67–75. https://doi.org/10.1039/c5mb00692a
  26. Новопашина Д.С., Назаров А.С., Воробьева М.А., Купрюшкин М.С., Давыдова А.С., Ломзов А.А., Пышный Д.В., Altman S., Веньяминова А.Г. // Мол. биология. 2018. T. 52. С. 1045–1054. https://doi.org/10.1134/S0026898418060137
  27. Garafutdinov R.R., Sakhabutdinova A.R., Kupryushkin M.S., Pyshnyi D.V. // Biochimie. 2020. V. 168. P. 259–267. https://doi.org/10.1016/j.biochi.2019.11.013
  28. Markov A.V., Kupryushkin M.S., Goncharova E.P., Amirkhanov R.N., Vasilyeva S.V., Pyshnyi D.V., Zenkova M.A., Logashenko E.B. // Russ. J. Bioorg. Chem. 2019. V. 45. P. 774–782. https://doi.org/10.1134/S1068162019060268
  29. Chubarov A.S., Oscorbin I.P., Filipenko M.L., Lomzov A.A., Pyshnyi D.V. // Diagnostics. 2020. V. 10. P. 872. https://doi.org/10.3390/diagnostics10110872
  30. Pavlova A.S., Yakovleva K.I., Epanchitseva A.V., Kupryushkin M.S., Pyshnaya I.A., Pyshnyi D.V., Ryabchikova E.I., Dovydenko I.S. // Int. J. Mol. Sci. 2021. V. 22. P. 9784. https://doi.org/10.3390/ijms22189784
  31. Kupryushkin M.S., Filatov A.V., Mironova N.L., Patutina O.A., Chernikov I.V., Chernolovskaya E.L., Zenkova M.A., Pyshnyi D.V., Stetsenko D.A., Altman S., Vlassov V.V. // Mol. Ther. Nucleic Acids. 2022. V. 27. P. 211–226. https://doi.org/10.1016/j.omtn.2021.11.025
  32. Stetsenko D., Kupryshkin M., Pyshnyi D. // Int. Application WO2016028187A1, 2016.
  33. Froehler B. // Tetrahedron Lett. 1986. V. 27. P. 5575– 5578. https://doi.org/10.1016/S0040-4039(00)85269-7
  34. Iyer R., Devlin T., Habus I., Yu D., Johnson S., Agrawal S. // Tetrahedron Lett. 1996. V. 37. P. 1543–1546. https://doi.org/10.1016/0040-4039(96)00067-6
  35. Peyrottes S., Vasseur J.-J., Imbach J., Rayner B. // Tetrahedron Lett. 1996. V. 37. P. 5869–5872. https://doi.org/10.1016/0040-4039(96)01250-6
  36. Laurent A., Debart F., Rayner B. // Tetrahedron Lett. 1997. V. 38. P. 5285–5288. https://doi.org/10.1016/S0040-4039(97)01153-2
  37. Devlin T., Iyer R., Johnson S., Agrawal S. // Bioorg. Med. Chem. Lett. 1996. V. 6. P. 2663–2668. https://doi.org/10.1016/S0960-894X(96)00498-2
  38. Peyrottes S., Vasseur J.-J., Imbach J.L., Rayner B. // Nucleosides and Nucleotides. 1997. V. 16. P. 1551– 1554. https://doi.org/10.1080/07328319708006227
  39. Iyer R., Yu D., Devlin T., Ho N.-H., Johnson S., Agrawal S. // Nucleosides and Nucleotides. 1997. V. 16. P. 1491–1495. https://doi.org/10.1080/07328319708006214
  40. Стеценко Д.А., Купрюшкин М.С., Пышный Д.В. // Заявка RU2014134383A, 2014.
  41. Paul S., Roy S., Monfregola L., Shang S., Shoemaker R., Caruthers M. // J. Am. Chem. Soc. 2015. V. 137. P. 3253–3264. https://doi.org/10.1021/ja511145h
  42. Prokhorova D.V., Chelobanov B.P., Burakova E.A., Fokina A.A., Stetsenko D.A. // Russ. J. Bioorg. Chem. 2017. V. 43. P. 38–42. https://doi.org/10.1134/S1068162017010071
  43. Chelobanov B.P., Burakova E.A., Prokhorova D.V., Fokina A.A., Stetsenko D.A. // Russ. J. Bioorg. Chem. 2017. V. 43. P. 664–668. https://doi.org/10.1134/S1068162017060024
  44. Kupryushkin M.S., Zharkov T.D., Ilina E.S., Markov O.V., Kochetkova A.S., Akhmetova M.M., Lomzov A.A., Pyshnyi D.V., Lavrik O.I., Khodyreva S.N. // Russ. J. Bioorg. Chem. 2021. V. 47. P. 719–733. https://doi.org/10.1134/S1068162021030110
  45. Carpino L., Han G. // J. Org. Chem. 1972. V. 37. P. 3404–3409. https://doi.org/10.1021/jo00795a005
  46. Bazhenov M.A., Shernyukov A.V., Kupryushkin M.S., Pyshnyi D.V. // Russ. J. Bioorg. Chem. 2019. V. 45. P. 699–708. https://doi.org/10.1134/S1068162019060074
  47. Jiménez E.I., Gibard C., Krishnamurthy R. // Angew. Chemie Int. Ed. 2021. V. 60. P. 10775–10783. https://doi.org/10.1002/anie.202015910
  48. Preobrazhenskaya N.N. // Russ. Chem. Rev. 1972. V. 41. P. 54–65. https://doi.org/10.1070/RC1972v041n01ABEH002030
  49. Johnsson R., Bogojeski J., Damha M. // Bioorg. Med. Chem. Lett. 2014. V. 24. P. 2146–2149. https://doi.org/10.1016/j.bmcl.2014.03.032
  50. Gololobov Y.G., Zhmurova I.N., Kasukhin L.F. // Tetrahedron. 1981. V. 37. P. 437–472. https://doi.org/10.1016/S0040-4020(01)92417-2
  51. Jones A. // Int. J. Biol. Macromol. 1979. V. 1. P. 194–207. https://doi.org/10.1016/0141-8130(79)90013-8
  52. Boal J., Wilk A., Harindranath N., Max E., Kempe T., Beaucage S. // Nucleic Acids Res. 1996. V. 24. P. 3115– 3117. https://doi.org/10.1093/nar/24.15.3115
  53. Pyshnyi D.V., Lomzov A.A., Pyshnaya I.A., Ivanova E.M. // J. Biomol. Struct. Dyn. 2006. V. 23. P. 567–579. https://doi.org/10.1080/07391102.2006.10507082
  54. Преч Э., Бюльманн Ф., Аффольтер К. // Определение строения органических соединений. Таблицы спектральных данных. Москва: Мир, 2006. 439 с.

补充文件

附件文件
动作
1. JATS XML
下载
2. Supplementary
下载 (989KB)
索引源数据
3. Fig. 1. ESI-MS analysis of compound (V) (Scheme 1) in positive ion recording mode.

下载 (134KB)
索引源数据
4. Fig. 2. (a) – RP-HPLC analysis of reaction mixtures of hexathymidylates (T*T5) obtained under different oxidation conditions according to the Staudinger reaction and treated with concentrated aqueous ammonia for 30 min at 25°C. Acetonitrile concentration gradient 0–30% over 15 min. Peak assignment was performed based on the combined data of mass spectrometric analysis (Fig. S4 in the supplementary materials) and comparison with the control oligonucleotide T6: peak 1 – T5, peak 2 – T6, peak 3 – T(–P(V)–NH2–)T5, peak 4 – T(–P(V)=N–Fmoc–)T5; (b) – oxidation conditions and the degree of the Staudinger reaction without taking into account the degree of destruction of the modified unit, obtained as the ratio of the sum of the integral areas of peaks 3 and 4 to the sum of the integral areas of all components of the reaction mixture (according to rHPLC data).

下载 (137KB)
索引源数据
5. Fig. 3. PAGE electrophoresis under denaturing conditions (8 M urea, 89 mM Tris-borate buffer, pH 8.3) of reaction mixtures of T*T5 oligonucleotides obtained according to the protocol described in Table 1, using 0.25 M FmocN3 solution and a Staudinger oxidation time of 45 min depending on the sequential postsynthetic treatment: 1, 2 – control T5 and T6, respectively; 3, 5 – ammonolysis (concentrated aqueous ammonia, 30 min), detritylation (80% acetic acid, 10 min); 4 – detritylation on CPG (3% trichloroacetic acid in CH2Cl2, 2 min), removal of the Fmoc group on CPG (2% DBU solution in acetonitrile, 5 min), ammonolysis (methanol-ammonia mixture, 2 h); 6 – ammonolysis (concentrated aqueous ammonia, 30 min), detritylation (80% acetic acid, 10 min), additional ammonolysis (concentrated aqueous ammonia, 24 h); 7 – ammonolysis (concentrated aqueous ammonia, 30 min), detritylation (80% acetic acid, 10 min), additional ammonolysis (methanol-ammonia mixture, 24 h). The assignment of the main spots was made according to ESI-MS analysis data after rHPLC extraction (Fig. S5 in the supplementary materials).

下载 (88KB)
索引源数据
6. Fig. 4. PAGE electrophoresis under denaturing conditions (8 M urea, 89 mM Tris-borate buffer, pH 8.3) of reaction mixtures: 1 and 2 – control oligonucleotides T5 and T6 with natural phosphodiester bonds; 3 – T2*T4, obtained by method 1; 4 – T2*T4, obtained by method 2.

下载 (179KB)
索引源数据
7. Fig. 5. Resistance of P-NH2 oligonucleotides to deprotection by a methanol-ammonia mixture compared to standard removal of protecting groups using concentrated aqueous ammonia, determined by rPLC data.

下载 (60KB)
索引源数据
8. Fig. 6. Experimental scheme for assessing the effect of the stage of additional oxidation with a mixture of I2/Py/H2O on the ratio of by-products in the synthesis of P-NH2 oligonucleotide. The effect was assessed using rHPLC data.

下载 (94KB)
索引源数据
9. Fig. 7. Contribution of P-NH2 modification to the thermal stability (DT) of complementary complexes of bimodified oligodeoxyribonucleotides with the AGCTACCG matrix depending on the ionic strength of the solution relative to the unmodified complex.

下载 (122KB)
索引源数据
10. Scheme 1. The steps of transformation of thymidine phosphite amido during oxidation of FmocN3 by the Staudinger reaction with indication of 31P-NMR characteristics obtained during the experiment. Compound (VI) was not registered during the transformations and is indicated here as the expected product with the range of chemical shifts presented in the literature [41, 47].

下载 (159KB)
索引源数据
11. Scheme 2. Proposed mechanism of hydrolysis of the Fmoc-containing fragment at the stage of detritylation with trichloroacetic acid during the synthesis of P-NH2 oligonucleotides.

下载 (58KB)
索引源数据

版权所有 © Russian Academy of Sciences, 2024